Current diagnostic techniques of assessingmyocardial viability in patients with hibernating and stunned myocardium

Circulation

Volumn 87, Issue 1, 1993, Pages 1-20

  Dilsizian, Vasken ^a   Bonow, Robert O ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; GLYCERYL TRINITRATE; RUBIDIUM 82; TECHNETIUM 99M; THALLIUM 201;

CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; GLUCOSE UTILIZATION; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HEART PERFUSION; HEART SCINTISCANNING; HUMAN; MYOCARDIAL DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CORONARY CIRCULATION; DOBUTAMINE; ECHOCARDIOGRAPHY; HEART; HUMAN; MAGNETIC RESONANCE IMAGING; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; RUBIDIUM RADIOISOTOPES; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0027508953     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.87.1.1     Document Type: Article

References (186)

1. Rees G, Bristow JD, Kremkau EL, Green GS, Herr RH, Griswold HE, Starr A: Influence of aortocoronary bypass surgery on left ventricular performance. N Engl J Med 1971;284:1116-1125
2. Chatterjee K, Swan HJC, Parmley WW, Sustaita H, Marcus HS, Matloff J: Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease. Circulation 1973;47:276-286
3. Rozanski A, Berman DS, Gray R, Levy R, Raymond M, Maddahi J, Pantelo N, Waxman AD, Swan HJC, Matloff J: Use of thallium-201 redistribution scintigraphy in the preoperative differentiation of reversible and nonreversible myocardial asynergy. Circulation 1981;64:936-944
4. Brundage BH, Massie BM, Botvinick EH: Improved regional ventricular function after successful surgical revascularization. J Am Coll Cardiol 1984;3:902-908
5. Dilsizian V, Bonow RO, Cannon RO, Tracy CM, Vitale DF, McIntosh CL, Clark RE, Bacharach SL, Green MV: The effect of coronary artery bypass grafting on left ventricular systolic function at rest: Evidence for preoperative subclinical myocardial ischemia. Am J Cardiol 1988;61:1248-1254
6. Bonow RO, Dilsizian V: Thallium-201 for assessing myocardial viability. Semin Nucl Med 1991;21:230-241
7. Nesto RW, Cohn LH, Collins JJ Jr, Wynne J, Holman L, Cohn PF: Inotropic contractile reserve: A useful predictor of increased 5-year survival and improved postoperative left ventricular function in patients with coronary artery disease and reduced ejection fraction. Am J Cardiol 1982;50:39-44
8. Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, Levine F, Schloss M: Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983;68:785-795
9. Pigott JD, Kouchoukos NT, Oberman A, Cutter GR: Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function. J Am Coll Cardiol 1985;5:1036-1045
10. Knoebel SB, Henry PL, Phillips JF, Pauletto FJ: Coronary collateral circulation and myocardial blood flow reserve. Circulation 1972;46:84-94
11. Levin DC: Pathways and functional significance of coronary collateral circulation. Circulation 1974;50:831-837
12. Schwarz F, Flameng W, Ensslen R, Sesto M, Thormann J: Effects of coronary collaterals on left ventricular function at rest and during stress. Am Heart J 1978;95:570-577
13. Goldberg HL, Goldstein J, Borer JS, Moses JW, Collins MB: Functional importance of coronary collateral vessels. Am J Cardiol 1984;53:694-699
14. Dilsizian V, Cannon RO, Tracy CM, McIntosh CL, Clark RE, Bonow RO: Enhanced regional left ventricular function after distant coronary bypass via improved collateral blood flow. J Am Coll Cardiol 1989;14:312-318
15. DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, Lang HT: Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:897-902
16. Banka VS, Bodenheimer MM, Helfant RH: Determinants of reversible asynergy: The native coronary circulation. Circulation 1975;52:810-816
17. Popio KA, Gorlin R, Bechtel D, Levine JA: Postextrasystolic potentiation as a predictor of potential myocardial viability: Preoperative analysis compared with studies after coronary bypass surgery. Am J Cardiol 1977;39:944-953
18. Rozanski A, Berman D, Gray R, Diamond G, Raymond M, Prause J, Maddahi J, Swan HJC, Matloff J: Preoperative prediction of reversible myocardial asynergy by postexercise radionuclide ventriculography. N Engl J Med 1982;307:212-216
19. Tillisch JH, Brunken R, Marshall R, Schwaiger M, Mandelkorn M, Phelps M, Schelbert H: Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-888
20. Heyndrickx GR, Baig H, Nelkins P, Leusen K, Fishbein MC, Vatner SF: Depression of regional blood flow and wall thickening after brief coronary occlusions. Am J Physiol 1978;234: H653-H659
21. Matsuzaki M, Gallagher KP, Kemper WS, White F, Ross J Jr: Sustained regional dysfunction produced by prolonged coronary stenosis: Gradual recovery after reperfusion. Circulation 1983;68: 170-182
22. Rahimtoola SH: Coronary bypass surgery for chronic angina - 1981: A perspective. Circulation 1982;65:225-241
23. Ross J Jr: Mechanisms of regional ischemia and antianginal drug action during exercise. Prog Cardiovasc Dis 1989;31:455-466
24. Perrone-Filardi P, Bacharach SL, Dilsizian V, Maurea S, Marin-Neto JA, Arrighi JA, Frank JA, Bonow RO: Metabolic evidence of viable myocardium in regions with reduced wall thickness and absent wall thickening in patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 1992;20:161-168
25. Rahimtoola SH: A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985;72(suppl V):V-123-V-135
26. Braunwald E, Kloner RA: The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation 1982;66: 1146-1149
27. Braunwald E, Rutherford JD: Reversible ischemic left ventricular dysfunction: Evidence for the 'hibernating myocardium.' J Am Coll Cardiol 1986;8:1467-1470
28. Ross J Jr: Myocardial perfusion-contraction matching: Implications for coronary heart disease and hibernation. Circulation 1991;83:1076-1082
29. Helfant RH, Pine R, Meister SG, Feldman MS, Trout RG, Banka VS: Nitroglycerin to unmask reversible asynergy: Correlation with postcoronary bypass ventriculography. Circulation 1974;50: 108-113
30. Bodenheimer MM, Banka VS, Hermann GA, Trout RG, Pasdar H, Helfant RH: Reversible asynergy: Histopathologic and electrographic correlations in patients with coronary artery disease. Circulation 1976;53:792-796
31. Horn HR, Teichholz LE, Cohn PF, Herman MV, Gorlin R: Augmentation of left ventricular contraction pattern in coronary artery disease by an inotropic catecholamine: The epinephrine ventriculogram. Circulation 1974;49:1063-1071
32. Dyke SH, Cohn PF, Gorlin R, Sonnenblick EH: Detection of residual myocardial function in coronary artery disease using post-extra systolic potentiation. Circulation 1974;50:694-699
33. Pohost GM, Zir LM, Moore RH, McKusick KA, Guiney TE, Beller GA: Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201. Circulation 1977;55:294-302
34. Schwartz JS, Ponto R, Carlyle P, Forstrom L, Cohn JN: Early redistribution of thallium-201 after temporary ischemia. Circulation 1978;57:332-335
35. Beller GA, Watson DD, Ackell P, Pohost GM: Time course of thallium-201 redistribution after transient myocardial ischemia. Circulation 1980;61:791-797
36. Blood DK, McCarthy DM, Sciacca RR, Cannon PJ: Comparison of single-dose and double-dose thallium-201 myocardial perfusion scintigraphy for the detection of coronary artery disease and prior myocardial infarction. Circulation 1978;58:777-788
37. Ritchie JL, Albro PC, Caldwell JH, Trobaugh GB, Hamilton GW: Thallium-201 myocardial imaging: A comparison of the redistribution and rest images. J Nucl Med 1979;20:477-483
38. Gibson RS, Watson DD, Taylor GJ, Crosby IK, Wellons HL, Holt ND, Beller GA: Prospective assessment of regional myocardial perfusion before and after coronary revascularization surgery by quantitative thallium-201 scintigraphy. J Am Coll Cardiol 1983;1: 804-815
39. Liu P, Kiess MC, Okada RD, Block PC, Strauss HW, Pohost GM, Boucher CA: The persistent defect on exercise thallium imaging and its fate after myocardial revascularization: Does it represent scar or ischemia? Am Heart J 1985;110:996-1001
40. Cloninger KG, DePuey EG, Garcia EV, Roubin GS, Robbins WL, Nody A, DePasquale EE, Berger HJ: Incomplete redistribution in delayed thallium-201 single photon emission computed tomographic images: An overestimation of myocardial scarring. J Am Coll Cardiol 1988;12:955-963
41. Kiat H, Berman DS, Maddahi J, Yang LD, Van Train K, Rozanski A, Friedman J: Late reversibility of tomographic myocardial thallium-201 defects: An accurate marker of myocardial viability. J Am Coll Cardiol 1988;12:1456-1463
42. Manyari DE, Knudtson M, Kloiber R, Roth D: Sequential thallium-201 myocardial perfusion studies after successful percutaneous transluminal coronary artery angioplasty: Delayed resolution of exercise-induced scintigraphic abnormalities. Circulation 1988; 77:86-95
43. Gutman J, Berman DS, Freeman M, Rozanski A, Maddahi J, Waxman A, Swan HJC: Time to completed redistribution of thallium-201 in exercise myocardial scintigraphy: Relationship to the degree of coronary artery stenosis. Am Heart J 1983;106: 989-995
44. Yang LD, Berman DS, Kiat H, Resser KJ, Friedman JD, Rozanski A, Maddahi J: The frequency of late reversibility in SPECT thallium-201 stress-redistribution studies. J Am Coll Cardiol 1989; 15:334-340
45. Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO: Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141-146
46. Rocco TP, Dilsizian V, McKusick KA, Fischman AJ, Boucher CA, Strauss HW: Comparison of thallium redistribution with rest 'reinjection' imaging for the detection of viable myocardium. Am J Cardiol 1990;66:158-163
47. Tamaki N, Ohtani H, Yonekura Y, Nohara R, Kambara H, Kawai C, Hirata K, Ban T, Konishi J: Significance of fill-in after thallium-201 reinjection following delayed imaging: Comparison with regional wall motion and angiographic findings. J Nucl Med 1990; 31:1617-1623
48. Ohtani H, Tamaki N, Yonekura Y, Mohiuddin IH, Hirata K, Ban T, Konishi J: Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol 1990;66:394-399
49. Budinger TF, Pohost GM: Thallium 'redistribution': An explanation. (abstract) J Nucl Med 1986;27:996
50. Budinger TF, Knittel BL: Cardiac thallium redistribution and model. (abstract) J Nucl Med 1987;28:588
51. Kayden DS, Sigal S, Soufer R, Mattera J, Zaret BL, Wackers FJ: Thallium-201 for assessment of myocardial viability: Quantitative comparison of 24-hour redistribution imaging with imaging after reinjection at rest. J Am Coll Cardiol 1991;18:1480-1486
52. Watson DD, Smith WH, Vinson E, Kaul S, Blackburn T, Beller GA: Quantitative analysis of rest reinjection compared to redistribution. (abstract) J Am Coll Cardiol 1992;19:129
53. Medrano R, Mahmarian JJ, Verani MS: Enhanced detection of ischemia after thallium reinjection using quantitative reversibility maps compared to visual analysis. (abstract) J Nucl Med 1992;33: 916
54. Dilsizian V, Smeltzer WR, Freedman NMT, Dextras R, Bonow RO: Thallium reinjection after stress-redistribution imaging: Does 24-hour delayed imaging following reinjection enhance detection of viable myocardium? Circulation 1991;83:1247-1255
55. Dae MW, Botvinick EH, Starksen NF, Zhu YY, Lapidus A: Do 4-hour reinjection thallium images and 24-hour thallium images provide equivalent information? (abstract) J Am Coll Cardiol 1991;17:29
56. McCallister BD, Clemments IP, Hauser MF, Gibbons RJ: The limited value of 24-hour images following 4-hour reinjection thallium imaging. (abstract) Circulation 1991;84(suppl II):II-533
57. Dilsizian V, Bonow RO: Differential uptake and apparent thallium-201 'washout' after thallium reinjection: Options regarding early redistribution imaging before reinjection or late redistribution imaging after reinjection. Circulation 1992;85:1032-1038
58. Kiat H, Friedman JD, Wang FP, Van Train KF, Maddahi J, Takemoto K, Berman DS: Frequency of late reversibility in stress-redistribution thallium-201 SPECT using an early reinjection protocol. Am Heart J 1991;122:613-619
59. Gewirtz H, Beller GA, Strauss HW, Dinsmore RE, Zir LM, McKusick KA, Pohost GM: Transient defects of resting thallium scans in patients with coronary artery disease. Circulation 1979; 59:707-713
60. Berger BC, Watson DD, Burwell LR, Crosby IK, Wellons HA, Teates CD, Beller GA: Redistribution of thallium at rest in patients with stable and unstable angina and the effect of coronary artery bypass surgery. Circulation 1979;60:1114-1125
61. Iskandrian AS, Hakki A, Kane SA, Goel IP, Mundth ED, Hakki A, Segal BL, Amenta A: Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary artery bypass grafting. Am J Cardiol 1983; 51:1312-1316
62. Mori T, Minamiji K, Kurogane H, Ogawa K, Yoshida Y: Rest-injected thallium-201 imaging for assessing viability of severe asynergic regions. J Nucl Med 1991;32:1718-1724
63. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW: Can resting thallium-201 imaging predict improvement in function after revascularization in patients with severely reduced LV function? (abstract) Circulation 1991;84:89
64. Dilsizian V, Bacharach SL, Perrone-Filardi P, Arrighi JA, Maurea S, Bonow RO: Concordance and discordance between rest-redistribution thallium imaging and thallium reinjection after stress-redistribution imaging for assessing viable myocardium: Comparison with metabolic activity by PET. (abstract) Circulation 1991;84:89
65. Scheibert HR, Phelps ME, Hoffman E, Huang SC, Kuhl DE: Regional myocardial blood flow, metabolism, and function assessed noninvasively with positron emission tomography. Am J Cardiol 1980;46:1269-1277
66. Marshall RC, Tillisch JH, Phelps ME, Huang SC, Carson R, Henze E, Schelbert HR: Identification and differentiation of rest-ing myocardial ischemia and infarction in man with positron emission tomography, F-18 labeled fluorodeoxyglucose, and N-13 ammonia. Circulation 1983;67:766-778
67. Schelbert HR, Buxton D: Insights into coronary artery disease gained from metabolic imaging. Circulation 1988;78:496-505
68. Fudo T, Kambara H, Hashimoto T, Hayashi M, Nohara R, Tamaki N, Yonekura Y, Senda M, Konishi J, Kawai C: F-18 deoxyglucose and stress N-13 ammonia positron emission tomography in anterior wall healed myocardial infarction. Am J Cardiol 1988;61:1191-1197
69. Tamaki N, Yonekura Y, Yamashita K, Saji H, Magata Y, Senda M, Konishi Y, Hirata K, Ban T, Konishi J: Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989;64:860-865
70. Neely JR, Rovetto MJ, Oram JF: Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 1972;15:289-329
71. Liedtke AJ: Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis 1981;23:321-336
72. Opie LH: Effects of regional ischemia on metabolism of glucose and fatty acids: Relative rates of aerobic and anaerobic energy production during myocardial infarction and comparison with effects of anoxia. Circ Res 1976;38(suppl I):I-52-I-74
73. Camici P, Ferrannini E, Opie LH: Myocardial metabolism in ischemic heart disease: Basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 1989; 32:217-238
74. Phelps ME, Schelbert HR, Mazziotta JC: Positron computer tomography for studies of myocardial and cerebral function. Ann Intern Med 1983;98:339-359
75. Neely JR, Rovetto MJ, Oram JF: Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 1972;15:289-329
76. Neely JR, Morgan HE: Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 1974;36:413-459
77. Krivokapich J, Huang SC, Phelps ME, Barrio JR, Watanabe CR, Selin CE, Shine KI: Estimation of rabbit myocardial metabolic rate for glucose using fluorodeoxyglucose. Am J Physiol 1982;243: H884-H895
78. Ratib O, Phelps ME, Huang SS, Henze E, Selin CE, Schelbert HR: Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med 1982;23:577-586
79. Nienaber CA, Brunken RC, Sherman CT, Yeatman LA, Gambhir SS, Krivokapich J, Demer LL, Ratib O, Child JS, Phelps ME, Schelbert HR: Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol 1991;18:966-978
80. Iida H, Rhodes CG, de Silva R, Yamamoto Y, Araujo LI, Maseri A, Jones T: Myocardial tissue fraction: Correction of partial volume effects and measure of tissue viability. J Nucl Med 1991; 32:2169-2175
81. Yamamoto Y, de Silva R, Rhodes CG, Araujo LI, Iida H, Rechavia E, Nihouannopoulos P, Hackett D, Galassi AR, Taylor CJV, Lammertsma AA, Jones T, Maseri A: A new strategy for the assessment of viable myocardium and regional myocardial blood flow using ISO-water and dynamic positron emission tomography. Circulation 1992;86:167-178
82. 18F-fluorodeoxyglucose. Circulation 1991;83:26-37
83. Dilsizian V, Freedman NMT, Bacharach SL, Perrone-Filardi P, Bonow RO: Regional thallium uptake in irreversible defects: Magnitude of change in thallium activity after reinjection distinguishes viable from nonviable myocardium. Circulation 1992;85: 627-634
84. Perrone-Filardi P, Bacharach SL, Dilsizian V, Maurea S, Frank JA, Bonow RO: Regional left ventricular wall thickening: Relation to regional uptake of 18-fluorodeoxyglucose and thallium-201 in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1992;86:1125-1137
85. Brunken R, Schwaiger M, Grover-McKay M, Phelps ME, Tillisch J, Schelbert HR: Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol 1987;10:557-567
86. Brunken RC, Kottou S, Nienaber CA, Schwaiger M, Ratib OM, Phelps ME, Schelbert HR: PET detection of viable tissue in myocardial segments with persistent defects at Tl-201 SPECT. Radiology 1989;65:65-73
87. Tamaki N, Yonekura Y, Yamashita K, Senda M, Saji H, Hashimoto T, Fudo T, Kambara H, Kawai C, Ban T, Konishi J: Relation of left ventricular perfusion and wall motion with metabolic activity in persistent defects on thallium-201 tomography in healed myocardial infarction. Am J Cardiol 1988;62:202-208
88. Tamaki N, Yonekura Y, Yamashita K, Mukai T, Magata Y, Hashimoto T, Fudo T, Kambara H, Kawai C, Hirata K, Ban T, Konishi J: SPECT thallium-201 tomography and positron tomography using N-13 ammonia and F-18 fluorodeoxyglucose in coronary artery disease. Am J Cardiac Imaging 1989;3:3-9
89. Tamaki N, Ohtani H, Yamashita K, Magata Y, Yonekura Y, Nohara R, Kambara H, Kawai C, Hirata K, Ban T, Konishi J: Metabolic activity in the areas of new fill-in after thallium-201 reinjection: Comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med 1991;32:673-678
90. Bonow RO, Bacharach SL, Cuocolo A, Dilsizian V: Severity of 'irreversible" thallium defects in myocardial regions with fluorodeoxyglucose-blood flow mismatch. (abstract) Circulation 1990; 82(suppl III):III-543
91. Gropler RJ, Siegel BA, Lee KJ, Moerlein SM, Perry DJ, Bergmann SR, Geltman EM: Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med 1990;31:1749-1756
92. Berry JJ, Baker JA, Pieper KS, Hanson MW, Hoffman JM, Coleman RE: The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers. J Nucl Med 1991;32:1518-1525
93. Reduto LA, Freund GC, Gaeta JM, Smalling RW, Lewis B, Gould KL: Coronary artery reperfusion in acute myocardial infarction: Beneficial effects of intracoronary streptokinase on left ventricular salvage and performance. Am Heart J 1981;102: 1168-1177
94. Anderson JL, Marshall HW, Bray BE, Lutz JR, Frederick PR, Yanowitz FG, Datz FL, Klausner SC, Hagan AD: A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. N Engl J Med 1983;308:1312-1318
95. Stack RS, Phillips HR III, Grierson DS, Behar VS, Kong Y, Peter RH, Swain JL, Greenfield JC: Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction. J Clin Invest 1983;72:84-95
96. Nixon JV, Brown CN, Smitherman TC: Identification of transient and persistent segmental wall motion abnormalities in patients with unstable angina by two-dimensional echocardiography. Circulation 1982;65:1497-1503
97. Renkin J, Wijns W, Ladha Z, Col J: Reversal of segmental hypokinesis by coronary angioplasty in patients with unstable angina, persistent T wave inversion, and left anterior descending coronary artery stenosis: Additional evidence for myocardial stunning in humans. Circulation 1990;82:913-921
98. 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina. Circulation 1986;74:81-88
99. Theroux P, Ross J Jr, Franklin D, Kemper WS, Sasayama MS: Coronary arterial reperfusion: III. Early and late effects on regional myocardial function and dimensions in conscious dogs. Am J Cardiol 1976;38:599-606
100. Greenfield RA, Swain JL: Disruption of myofibrillar energy use: Dual mechanisms that may contribute to postischemic dysfunction in stunned myocardium. Circ Res 1987;60:283-289
101. McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159-163
102. Przyldenk K, Kloner RA: Superoxide dismutase plus catalase improve contractile function in the canine model of 'stunned myocardium.' Circ Res 1986;58:148-156
103. Krause SM, Jacobus WE, Becker LC: Alterations in sarcoplasmic reticulum calcium transport in the postischemic 'stunned' myocardium. Circ Res 1989;65:526-530
104. 2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret heart. J Clin Invest 1987;79:950-961
105. Przyklenk K, Kloner RA: Effects of verapamil on postischemic 'stunned' myocardium: Importance of timing of treatment. J Am Coll Cardiol 1988;11:614-623
106. Engler R, Covell JW: Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog. Circ Res 1987; 61:20-28
107. Zhao M, Zhang H, Robinson TF, Factor SM, Sonnenblick EH, Eng C: Profound structural alterations of the extracellular collagen matrix in postischemic dysfunction ('stunned') but viable myocardium. J Am Coll Cardiol 1987;10:1322-1334
108. Ritchie JL, Davis KB, Williams DL, Caldwell J, Kennedy JW: Global and regional left ventricular function and tomographic radionuclide perfusion: The Western Washington intracoronary streptokinase in myocardial infarction trial. Circulation 1984;70: 867-875
109. Gruppo Italiano per lo Studio della Streptochinasi Nell'Infarto Miocardico (GISSI): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-401
110. Simoons ML, Serruys PW, van den Brand M, Res J, Verheugt FWA, Krauss XH, Remme WJ, Bar F, deZwaan C, van der Laarse A, Vermeer F, Lubsen J: Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survival. J Am Coll Cardiol 1986;7:717-728
111. Prigent F, Maddahi J, Garcia EV, Saitoh Y, VanTrain K, Berman D: Quantification of myocardial infarct size by thallium-201 single-photon emission computerized tomography: Experimental validation in the dog. Circulation 1986;74:852-861
112. Krivokapich J, Watanabe CR, Shine KI: Effects of anoxia and ischemia on thallium exchange in rapid myocardium. Am J Physiol 1985;249:H620-H628
113. Moore CA, Cannon J, Watson DD, Kaul S, Beller GA: Thallium-201 kinetics in stunned myocardium characterized by severe postischemic systolic dysfunction. Circulation 1990;81:1622-1632
114. Maddahi J, Ganz W, Ninomiya K, Hashida J, Fishbein MC, Mondkar A, Buchbinder N, Shah PK, Swan HJC, Berman DS: Myocardial salvage by intracoronary thrombolysis in evolving myocardial infarction: Evaluation using intracoronary injection of thallium-201. Am Heart J 1981;102:664-674
115. Markis JE, Malagold M, Parker JA, Silverman KJ, Barry WH, Als AV, Paulin S, Grossman W, Braunwald E: Myocardial salvage after intracoronary thrombolysis with streptokinase in acute myocardial infarction. N Engl J Med 1981;305:777-782
116. Beller GA: Role of myocardial perfusion imaging in evaluating thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol 1987;9:661-668
117. Granato JE, Watson DD, Flanagan TL, Gascho JA, Beller GA: Myocardial thallium-201 kinetics during coronary occlusion and reperfusion: Influence of method of reflow and timing of thallium-201 administration. Circulation 1986;73:150-160
118. Okada RD, Pohost GM: The use of preintervention and postintervention thallium imaging for assessing the early and late effects of experimental coronary arterial reperfusion in dogs. Circulation 1984;69:1153-1160
119. Melin JA, Becker LC, Bukley BH: Differences in thallium-201 uptake in reperfused and nonreperfused myocardial infarction. Circ Res 1983;53:414-419
120. Forman R, Kirk ES: Thallium-201 accumulation during reperfusion of ischemic myocardium: Dependence on regional blood flow rather than viability. Am J Cardiol 1983;54:659-663
121. Okada RD: Kinetics of thallium-201 in reperfused canine myocardium after coronary artery occlusion. J Am Coll Cardiol 1984; 3:1245-1251
122. Simoons ML, Wijns W, Balakumaran K, Serruys PW, van den Brand M, Fioretti P, Reiber JHC, Lie P, Hugenholtz PG: The effect of intracoronary thrombolysis with streptokinase on myocardial thallium distribution and left ventricular function assessed by blood-pool scintigraphy. Eur Heart J 1982;3:433-440
123. DeCoster PM, Melin JA, Detry JMR, Brasseur LA, Beckers C, Col J: Coronary artery reperfusion in acute myocardial infarction: Assessment by pre- and postintervention thallium-201 myocardial perfusion imaging. Am J Cardiol 1985;55:889-895
124. Mahmarian JJ, Pratt EM, Borges-Neto S, Cushion WR, Roberts R, Verani MS: Quantification of infarct size by thallium-201 single-photon emission computed tomography during acute myocardial infarction in humans: Comparison with enzymatic estimates. Circulation 1988;78:831-839
125. Schwartz F, Schuler G, Katus H, Mehmel HC, von Olshausen K, Hofmann M, Hermann H-J, Kubler W: Intracoronary thrombolysis in acute myocardial infarction: Correlation among serum enzyme, scintigraphic and hemodynamic findings. Am J Cardiol 1982;50:32-38
126. Goldstein RA: Kinetics of rubidium-82 after coronary occlusion and reperfusion: Assessment of patency and viability in open-chested dogs. J Clin Invest 1985;75:1131-1137
127. Gould KL, Yoshida K, Hess MJ, Haynie M, Mullani N, Smalling RW: Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET. J Nucl Med 1991;32:1-9
128. Schwaiger M, Schelbert HR, Ellison D, Hansen H, Yeatman L, Vinten-Johansen J, Selin C, Barrio J, Phelps ME: Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll Cardiol 1985;6:336-347
129. Liedtke AJ, DeMaison L, Eggleston AM, Cohen LM, Nellis SH: Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ Res 1988;62:535-542
130. Mochizuki S, Neely JR: Energy metabolism during reperfusion following ischemia. J Physiol (Paris) 1980;76:805-812
131. Myears DW, Sobel BE, Bergmann SR: Substrate use in ischemic and reperfused canine myocardium: Quantitative considerations. Am J Physiol 1987;253:H107-H114
132. Renstrom B, Nellis SH, Liedtke AJ: Metabolic oxidation of glucose during early myocardial reperfusion. Circ Res 1989;65: 1094-1101
133. Renstrom B, Nellis SH, Liedtke AJ: Metabolic oxidation of pyruvate and lactate during early myocardial reperfusion. Circ Res 1990;66:282-288
134. Schwaiger M, Brunken R, Grover-McKay M, Krivokapich J, Child J, Tillisch JH, Phelps ME, Schelbert HR: Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography. J Am Coll Cardiol 1986;8:800-808
135. Sebree L, Bianco JA, Subramanian R, Wilson MA, Swanson D, Hegge J, Tschudy J, Pyzalski R: Discordance between accumulation of C-14 deoxyglucose and Tl-201 in reperfused myocardium. J Mol Cell Cardiol 1991;23:603-616
136. Taegtmeyer H, Robers AFC, Raine AEG: Energy metabolism in reperfused heart muscle: Metabolic correlates of return of function. J Am Coll Cardiol 1985;6:864-870
137. 11C] acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation 1990;81:1594-1605
138. Vanoverschelde JJ, Melin JA, Bol A, Vanbutsele R, Cogneau M, Labar D, Robert A, Michel C, Wijns W: Regional oxidative metabolism in patients after recovery from reperfused anterior myocardial infarction: Relation to regional blood flow and glucose uptake. Circulation 1992;85:9-21
139. Gropler RJ, Siegel BA, Sampathkumaran K, Perez JE, Geltman EM: Maintenance of oxidative metabolism determines recovery of contractile and metabolic function after myocardial infarction. (abstract) Circulation 1990;82(suppl III):III-479
140. Hood WB, Covell VH, Abelman WH, Norman JC: Persistence of contractile behavior in acutely ischaemic myocardium. Cardiovasc Res 1969;3:249-260
141. Dyke SH, Urschel CW, Sonnenblick EH, Gorlin R, Cohn PF: Detection of latent function in acutely ischemic myocardium in the dog: Comparison of pharmacologic inotropic stimulation and postextrasystolic potentiation. Circ Res 1975;36:490-497
142. Mercier JC, Lando U, Kanmatsuse K, Ninomlya K, Meerbaum S, Fishbein MC, Swan HJC, Ganz W: Divergent effects of inotropic stimulation on the ischemic and severely depressed reperfused myocardium. Circulation 1982;66:397-400
143. Ellis SG, Wynne J, Braunwald E, Henschke CI, Sandor T, Kloner RA: Response of reperfusion-salvaged stunned myocardium to inotropic stimulation. Am Heart J 1984;107:13-19
144. Bolli R, Zhu WX, Myers ML, Hartley CJ, Roberts R: Beta-adrenergic stimulation reverses postischemic myocardial dysfunction without producing subsequent functional deterioration. Am J Cardiol 1985;56:964-968
145. Becker LC, Levine JH, Di Paula AF, Guarnieri T, Aversano T: Reversal of dysfunction in postischemic stunned myocardium by epinephrine and postextrasystolic potentiation. J Am Coll Cardiol 1986;7:580-589
146. Satler LF, Kent KM, Fox LM, Goldstein HA, Green CE, Rogers WJ, Pallas RS, Del Negro AA, Pearle DL, Rackley CE: The assessment of contractile reserve after thrombolytic therapy for acute myocardial infarction. Am Heart J 1986;111:821-825
147. Pierard LA, De Lansheere CM, Berthe C, Rigo P, Kulbertus HA: Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography. J Am Coll Cardiol 1990;15:1021-1031
148. Smart S, Sawada S, Ryan T, Atherton L, Segar DS, Bourdillon P, Armstrong WF, Feigenbaum H: Dobutamine echocardiography predicts recovery after thrombolysis in myocardial infarction. (abstract) Circulation 1990;82(suppl III):III-74
149. Smart S, Sawada S, Segar D, Ryan T, Bourdillon P, Feigenbaum H: Low-dose dobutamine echocardiography to assess prognosis after thrombolysis for myocardial infarction. (abstract) Circulation 1991;84(suppl II):II-478
150. Barilla F, Gheorghiade M, Alam M, Khaja F, Goldstein S: Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J 1991;122: 1522-1531
151. Charney R, Schwinger ME, Cohen MV, Menegus M, Spindola-Franco H, Greenberg MA: Dobutamine echocardiography predicts recovery of hibernating myocardium following coronary revascularization. (abstract) J Am Coll Cardiol 1992;19:176A
152. Leppo JA, DePuey EG, Johnson LL: A review of cardiac imaging with sestamibi and teboroxime. J Nucl Med 1991;32:2012-2022
153. Maddahi J, Kiat H, Berman DS: Myocardial perfusion imaging with technetium-99m-labeled agents. Am J Cardiol 1991;67: 27D-34D
154. Mullins LJ, Moore RD: The movement of thallium ions in muscle. J Gen Physiol 1960;43:759-773
155. Gehring PJ, Hammond PB: The interrelationship between thallium and potassium in animals. J Pharmacol Exp Ther 1967;155: 187-201
156. Meerdink DJ, Leppo JA: Comparison of hypoxia and ouabain effects on the myocardial uptake kinetics of technetium-99m hexakis 2-methoxy-isobutyl isonitrile and thallium-201. J Nucl Med 1989;30:1500-1506
157. Piwnica-Worms D, Kronauge JF, Chiu ML: Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium (I) in cultured chick myocardial cells: Mitochondrial and plasma membrane potential dependence. Circulation 1990;82:1826-1838
158. Leppo JA, Meerdink DJ: Comparison of the myocardial uptake of a technetium-labeled isonitrile analogue and thallium. Circ Res 1989;65:632-639
159. Beanlands RSB, Dawood F, Wen WH, Mclaughlin PR, Butany J, D'Amati G, Liu PP: Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? Circulation 1990;82:1802-1814
160. 99mTc-sestamibi. (abstract) Circulation 1990;82(suppl III):III-542
161. Dilsizian V, Rocco TP, Strauss HW, Boucher CA: Technetium-99m isonitrile myocardial uptake at rest: I. Relation to severity of coronary artery stenosis. J Am Coll Cardiol 1989;14:1673-1677
162. Rocco TP, Dilsizian V, Strauss HW, Boucher CA: Technetium-99m isonitrile myocardial uptake at rest: II. Relation to clinical markers of potential viability. J Am Coll Cardiol 1989;14: 1678-1684
163. Sinusas AJ, Watson DD, Cannon JM, Beller GA: Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyl isonitrile and thallium-201. J Am Coll Cardiol 1989;14:1785-1793
164. Verani MS, Jeroudi MO, Mahmarian JJ, Boyce TM, Borges-Neto S, Patel B, Bolli R: Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxybutyl isonitrile. J Am Coll Cardiol 1988;12:1573-1581
165. Sinusas AJ, Trautman KA, Bergin JD, Watson DD, Ruiz M, Smith WH, Beller GA: Quantification of 'area at risk' during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m-methoxyisobutyl-isonitrile. Circulation 1990;82:1424-1437
166. Gibbons RJ, Verani MS, Behrenbeck T, Pellikka PA, O'Connor MK, Mahmarian JJ, Chesebro JH, Wackers FJ: Feasibility of tomographic technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of acute treatment in myocardial infarction. Circulation 1989;80:1277-1286
167. Christian TF, Behrenbeck T, Pellikka PA, Huber KC, Chesebro JH, Gibbons RJ: Mismatches of left ventricular function and perfusion with Tc-99m-isonitrile following reperfusion therapy for acute myocardial infarctions: Identification of myocardial stunning and hyperkinesia. J Am Coll Cardiol 1990;16:1632-1638
168. Hendel RC, Dahlberg ST, Parker M, McSherry BA, Weinstein H, Leppo JA: Comparative assessment of myocardial viability with thallium-201 and Tc-99m-teboroxime planar imaging. (abstract) Circulation 1991;84(suppl II):II-90
169. Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Trimarco B, Salvatore M: Identification of viable myocardium in patients with chronic coronary artery disease: Comparison of thallium-201 scintigraphy with reinjection and technetium-99m methoxyisobutyl isonitrile. J Nucl Med 1992;33:505-511
170. Bonow RO, Dilsizian V: Thallium-201 and technetium-99m-sestamibi for assessing viable myocardium. J Nucl Med 1992;33: 815-818
171. Dilsizian V, Marin-Neto JA, Arrighi JA, Bacharach SL, Perrone-Filardi P, Bonow RO: Myocardial viability: Comparison of thallium reinjection, rest-stress sestamibi, and positron emission tomography. (abstract) J Am Coll Cardiol 1992;19:21A
172. Li QS, Solot G, Frank TL, Wagner HN, Becker LC: Myocardial redistribution of technetium-99m-methoxyisobutyl isonitrile (sestamibi). J Nucl Med 1990;31:1069-1076
173. Taillefer R, Primeau M, Costi P, Lambert R, Leveille J, Latour Y: Technetium-99m-sestamibi myocardial perfusion imaging in detection of coronary artery disease: Comparison between initial (1-hour) and delayed (3-hour) postexercise images. J Nucl Med 1991;32:1961-1965
174. Sinusas AJ, Bergin JD, Edwards NC, Watson DD, Rutz M, Beller GA: Technetium-99m isonitrile and thallium-201 activity are comparable following 3 hours of low-flow ischemia. (abstract) J Am Coll Cardiol 1990;15:8A
175. Sinusas AJ, Bergin JD, Edwards NC, Watson DD, Ruiz M, Smith WH, Beller GA: Comparison of Tc-99m methoxyisobutyl isonitrile and Tl-201 uptake during low-flow ischemia. (abstract) J Nucl Med 1990;31:713
176. Coleman PS, Metherall JA, Cao Q, Pandian N, Griffith JL, Shea NL, Oates E, Konstam MA, Udelson JE: Comparison of rest-redistribution thallium-201 uptake with resting sestamibi uptake in coronary artery disease. (abstract) J Nucl Med 1992;33:905
177. Arrighi JA, Diodati JG, Bacharach SL, Uddin S, Bonow RO, Dilsizian V: The detection of viable myocardium by Tc-99m sestamibi is enhanced when the severity of irreversible defects are assessed. (abstract) Circulation 1992;(suppl I)86:I-108
178. Stewart RE, Schwaiger M, Hutchins GD, Chiao PC, Gallagher KP, Nguyen N, Petry NA, Rogers WL: Myocardial clearance kinetics of technetium-99m SQ30217: A marker of regional myocardial blood flow. J Nucl Med 1990;31:1183-1190
179. Higgins CB, Herfkens R, Lipton MJ, Sievers R, Sheldon P, Kaufman L, Crooks LE: Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: Alterations in magnetic relaxation times. Am J Cardiol 1983;52:184-188
180. Ratner AAV, Okada RD, Newell JB, Pohost GM: The relationship between proton nuclear magnetic resonance relaxation parameters and myocardial perfusion with acute coronary arterial occlusion and reperfusion. Circulation 1985;71:823-828
181. McNamara MT, Higgins CB, Schechtmann N, Botvinick E, Lipton MJ, Chatterjee K, Amparo EG: Detection and characterization of acute myocardial infarction in man with use of gated magnetic resonance. Circulation 1985;71:717-724
182. Canby RC, Reeves RC, Evanochko WT, Elgavish GA, Pohost GM: Proton nuclear magnetic resonance relaxation times in severe myocardial ischemia. J Am Coll Cardiol 1987;10:412-420
183. Ryan T, Tarver RD, Duerk JL, Sawada SG, Hollenkamp NC: Distinguishing viable from infarcted myocardium after experimental ischemia and reperfusion by using nuclear magnetic resonance imaging. J Am Coll Cardiol 1990;15:1355-1364
184. McNamara MT, Tscholakoff D, Revel D, Soulen R, Schechtmann N, Botvinick E, Higgins CB: Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA. Radiology 1986;158:765-769
185. Wedland MF, Saeed M, Takehara Y, Higgins CB: Non-ionic Gd-DTPA-BMA gas: The potential to differentiate between reversible and irreversible myocardial injury. (abstract) Circulation 1989;80(suppl II):II-237
186. Pettigrew RI, Brownell A-L, Holmvang G, Rozenman Y, Kantor HL, Southern JF, McKinstry R, Rowell D, Brownell GL, Rosen BR: Iron oxide MRI of myocardial tissue blood delivery post acute infarction: Comparison with quantitative PET. (abstract) Circulation 1989;80(suppl II):II-232